A detailed history of Wedge Capital Management L L P transactions in Abb Vie Inc. stock. As of the latest transaction made, Wedge Capital Management L L P holds 164,552 shares of ABBV stock, worth $28.3 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
164,552
Previous 212,439 22.54%
Holding current value
$28.3 Million
Previous $36.4 Million 10.82%
% of portfolio
0.57%
Previous 0.65%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$163.84 - $199.33 $7.85 Million - $9.55 Million
-47,887 Reduced 22.54%
164,552 $32.5 Million
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $959,543 - $1.12 Million
-6,199 Reduced 2.84%
212,439 $36.4 Million
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $2.03 Million - $2.31 Million
12,673 Added 6.15%
218,638 $39.8 Million
Q4 2023

Feb 01, 2024

SELL
$137.6 - $154.97 $1.12 Million - $1.26 Million
-8,155 Reduced 3.81%
205,965 $31.9 Million
Q3 2023

Oct 13, 2023

SELL
$133.59 - $154.65 $1.94 Million - $2.24 Million
-14,492 Reduced 6.34%
214,120 $31.9 Million
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $1.28 Million - $1.59 Million
-9,655 Reduced 4.05%
228,612 $30.8 Million
Q1 2023

Apr 11, 2023

SELL
$144.61 - $166.54 $1.39 Million - $1.6 Million
-9,596 Reduced 3.87%
238,267 $38 Million
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $1.13 Million - $1.36 Million
-8,172 Reduced 3.19%
247,863 $40.1 Million
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $1.15 Million - $1.31 Million
8,532 Added 3.45%
256,035 $34.4 Million
Q2 2022

Jul 11, 2022

BUY
$137.62 - $174.96 $3.17 Million - $4.03 Million
23,055 Added 10.27%
247,503 $37.9 Million
Q1 2022

Apr 12, 2022

SELL
$131.98 - $163.75 $7 Million - $8.68 Million
-53,026 Reduced 19.11%
224,448 $36.4 Million
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $672,189 - $850,514
6,257 Added 2.31%
277,474 $37.6 Million
Q3 2021

Oct 14, 2021

SELL
$106.4 - $120.78 $1.38 Million - $1.56 Million
-12,955 Reduced 4.56%
271,217 $29.3 Million
Q2 2021

Jul 14, 2021

SELL
$105.21 - $117.21 $900,808 - $1 Million
-8,562 Reduced 2.92%
284,172 $32 Million
Q1 2021

Apr 12, 2021

BUY
$102.3 - $112.62 $29.9 Million - $33 Million
292,734 New
292,734 $31.7 Million
Q3 2020

Oct 08, 2020

SELL
$85.91 - $100.83 $339,774 - $398,782
-3,955 Closed
0 $0
Q2 2020

Jul 10, 2020

BUY
$73.37 - $98.18 $33,676 - $45,064
459 Added 13.13%
3,955 $388,000
Q1 2020

Apr 13, 2020

SELL
$64.5 - $97.79 $30.2 Million - $45.8 Million
-468,323 Reduced 99.26%
3,496 $266,000
Q4 2019

Jan 15, 2020

SELL
$72.13 - $90.25 $945,984 - $1.18 Million
-13,115 Reduced 2.7%
471,819 $41.8 Million
Q3 2019

Nov 01, 2019

BUY
$62.98 - $75.72 $2.98 Million - $3.58 Million
47,265 Added 10.8%
484,934 $36.7 Million
Q2 2019

Aug 01, 2019

BUY
$65.7 - $83.98 $28.8 Million - $36.8 Million
437,669 New
437,669 $31.8 Million
Q1 2019

May 02, 2019

SELL
$77.14 - $90.79 $178,424 - $209,997
-2,313 Closed
0 $0
Q4 2018

Jan 31, 2019

SELL
$77.85 - $96.01 $7,473 - $9,216
-96 Reduced 3.99%
2,313 $213,000
Q3 2018

Nov 01, 2018

BUY
$88.91 - $98.84 $14,759 - $16,407
166 Added 7.4%
2,409 $228,000
Q2 2018

Jul 31, 2018

BUY
$89.78 - $106.23 $201,376 - $238,273
2,243 New
2,243 $208,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wedge Capital Management L L P Portfolio

Follow Wedge Capital Management L L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.